‘Rare’ blood clot issues prompt EMA to suggest dropping AstraZeneca COVID jab
3 years ago
72
A top European Medicines Agency official has suggested ditching the AstraZeneca COVID jab for all age groups because of worries about ‘blood clotting’, while some European countries have already suspended the use of the inoculation for the same reason.
Follow us on Telegram https://t.me/rtintl / https://t.me/rtvisual
Loading 2 comments...
-
LIVE
RT
1 year agoRT News | Livestream 24/7
1,802 watching -
1:21
Reuters
3 years agoAstraZeneca finds no increased blood clot risk
2673 -
4:39
RT
3 years agoPeople reluctant to take AstraZeneca jab over blood clot fears
17 -
3:15
KGTV
3 years agoAstraZeneca and blood clots
3211 -
1:27
WFTX
3 years agoCovid vaccination distribution issues continue
132 -
1:49
Reuters
3 years agoAstraZeneca COVID vaccine is safe -EU watchdog
2055 -
0:22
Newsy
3 years agoAstraZeneca Delivers COVID Vaccines To EU and U.K.
8122 -
2:19
KNXV
3 years agoCould COVID cause blood clots?
262 -
0:31
Newsy
3 years agoSeveral EU Countries Suspend AstraZeneca COVID Vaccine Use
1.62K4 -
0:53
KTNV
3 years agoOfficials: CA man develops blood clot after receiving J&J COVID vaccine
2192